Presents the reasons for the decline in gene therapy protocols. Cancellation of the March 1996 meeting by the 25-member Recombinant DNA Advisory Committee on the grounds that it does not have any protocols to review; Explanation of the decline as the pause in research as it moves from one level up to the next.